| Financial Year |
March 31 2023 |
| Monetary Funds |
2,281,350,893.83 |
| Held-for-trading Financial Assets |
1,277,068,509.22 |
| Notes Receivable |
23,778,721.68 |
| Accounts Receivable |
4,143,864,617.80 |
| Advances to Suppliers |
160,822,581.52 |
| Other Receivables |
175,822,886.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
64,944,484.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
37,912,850.72 |
| Other Current Assets |
83,095,760.40 |
| Total Current Assets |
11,910,315,954.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
62,965,198.18 |
| Long-term Equity Investment |
57,078,181.73 |
| Investment Properties |
31,496,453.73 |
| Fixed Assetes |
562,291,555.10 |
| Under-construction Projects |
42,326,644.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
248,156,868.02 |
| R&D expenses |
-- |
| Goodwill |
560,833,464.51 |
| Long-Term Deferred and Prepaid Expenses |
51,057,110.03 |
| Deferred Income Tax Assets |
540,236,599.99 |
| Other Non-Current Assets |
78,071,476.56 |
| Sub-Total of Non-Current Assets |
3,210,894,129.24 |
| Total Assets |
15,121,210,083.24 |
| Short-Term Loans |
1,548,079,831.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,890,000.00 |
| Accounts Payable |
2,559,479,774.21 |
| Accounts Received In Advance |
798,947.48 |
| Employee Compensation Payable |
162,936,060.75 |
| Taxes Payable |
558,458,232.81 |
| Interest Payable |
-- |
| Dividend Payable |
387,247.35 |
| Other payables |
225,384,917.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
380,947,779.04 |
| Other Current Liabilities |
30,294,449.62 |
| Sub-Total of Current Liabilities |
5,794,261,050.48 |
| Long-term Loans |
432,003,200.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,908,071.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,435,546.37 |
| Deferred Income Tax Liabilities |
13,994,868.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
695,426,151.49 |
| Total Liabilities |
6,489,687,201.97 |
| Paid-In Capital(Or Share Stock) |
1,262,827,774.00 |
| Capital Surplus |
3,065,714,499.47 |
| Surplus Reserve |
239,600,668.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,704,555,566.16 |
| Minority Stockholder's Interest |
395,587,347.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,235,935,533.86 |
| Owner's Equity（Stockholder's Equity） |
8,631,522,881.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,121,210,083.24 |
